Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Beatriz, Castelo Fernández"'
Autor:
Juan Francisco Peña-Cardelles, José Juan Pozo-Kreilinger, Giovanna Roncador, Jesús Esteban-Hernández, José Ernesto Moro-Rodríguez, Ana Sastre-Perona, Beatriz Castelo-Fernández, José Luis Cebrián-Carretero
Publikováno v:
Biomedicines, Vol 10, Iss 3, p 710 (2022)
Objectives: To evaluate the relationship of the immune-checkpoint PD-1/PD-L1 with the clinical evolution of OSCC; to assess survival in OSCC based on the characteristics of TME and histologic risk score; to evaluate the clinical and histopathological
Externí odkaz:
https://doaj.org/article/8146f68f08c24386be33b6bf78eac32f
Autor:
Paula González Villarroel, Josep Gumà Padró, Gloria Marquina, Noelia Martínez Jáñez, Emilio Esteban González, Antonio Antón, Miguel Berzosa Sánchez, Alberto Rodrigo Cáceres, Rafael López-López, Roberto Escala Cornejo, Pablo Borrega García, Raquel Marse Fabregat, Beatriz Castelo Fernández, Cristina López Bermudo, Carlos Camps
Publikováno v:
González Villarroel, Paula Gumà Padró, Josep Marquina, Gloria Martínez Jáñez, Noelia Esteban González, Emilio Antón, Antonio Berzosa Sánchez, Miguel Rodrigo Cáceres, Alberto López López, Rafael Escala Cornejo, Roberto Borrega García, Pablo Marse Fabregat, Raquel Castelo Fernández, Beatriz López Bermudo, Cristina Camps Herrero, Carlos 2022 Increased quality of life in patients with breakthrough cancer pain after individualized therapy : the CAVIDIOM study Future Oncology 18 35 3913 3927
Cancer patients can experience flares of pain, called breakthrough pain (BTcP), despite treatment with painkillers. Although BTcP can be excruciating, its intensity and other characteristics depend on several factors, including its treatment. However
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::649f6ff8416de9fdc212b930b89bee23
https://pubmed.ncbi.nlm.nih.gov/36537885
https://pubmed.ncbi.nlm.nih.gov/36537885
Autor:
Isabel Torres-Sánchez, Beatriz Castelo-Fernández, Laura Yébenes-Gregorio, Óscar Moreno-Domínguez, Rosa M. García-Moreno, Cristina Álvarez-Escolá
Publikováno v:
Oncology Research and Treatment. 44:568-572
Introduction: Tyrosine kinase inhibitors have been a breakthrough in the treatment of advanced medullary thyroid cancer (MTC), and they can prolong progression-free survival (PFS). Case Presentation: A patient with MTC and metastatic spread to the ly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d95953d2ae28f2f15cd22258708279a5
https://doi.org/10.1159/000518673
https://doi.org/10.1159/000518673
Autor:
Antonio Llombart-Cussac, Jose Perez-Garcia, Beatriz Castelo Fernández, Alfonso Cortés Salgado, Elena Lopez Miranda, François Riva, Andrea Malfettone, Ana López González, I Garau, Miguel Sampayo, Javier Cortes, Pedro Sánchez Rovira, Miguel Corbellas Aparicio, Alejandro Martínez, Antonio Antón, Sonia Del Barco
Publikováno v:
Cancer Research. 80:OT2-09
BACKGROUND: Previous studies have shown prolonged overall survival (OS) in patients with metastatic breast cancer (MBC) treated with eribulin, without a clear improvement in progression-free survival (PFS), which might indicate an eribulin-mediated s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52e8a647968eaf6e24d6cd97c2f332fe
https://doi.org/10.1158/1538-7445.sabcs19-ot2-09-01
https://doi.org/10.1158/1538-7445.sabcs19-ot2-09-01
Autor:
Antonio Rueda Domínguez, Beatriz Cirauqui, Almudena García Castaño, Ruth Alvarez Cabellos, Alberto Carral Maseda, Beatriz Castelo Fernández, Leticia Iglesias Rey, Jordi Rubió-Casadevall, Virginia Arrazubi, Ricard Mesía
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 24(4)
Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiotherapy (RT) is the cornerstone of locoregional treatment of non-disseminated dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7482045cba4328ba732312bc2617c2d5
https://pubmed.ncbi.nlm.nih.gov/35303267
https://pubmed.ncbi.nlm.nih.gov/35303267
Autor:
Ana López González, Sonia Del Barco Berrón, Isabel Grau, Maria Galan, Beatriz Castelo Fernández, Alfonso Cortés, Pedro Sánchez Rovira, Alejandro Martinez-Bueno, Xavier Gonzalez, Almudena García, Petra Gener, Leonardo Mina, Daniel Alcalá-López, Miguel Sampayo, Javier Cortés, José Manuel Pérez-Garcia, Antonio Llombart-Cussac, Elena López-Miranda
Publikováno v:
Cancers; Volume 14; Issue 23; Pages: 5880
Background: Luminal advanced breast cancer (ABC) patients eventually progress on endocrine therapy. REVERT aimed to explore whether eribulin could restore endocrine sensitivity in a randomized, non-comparative phase II trial. Methods: Aromatase inhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30b6d2a9b417942df6831d7efd77614a
https://doi.org/10.3390/cancers14235880
https://doi.org/10.3390/cancers14235880
Autor:
Andrés Redondo Sánchez, Enrique Espinosa Arranz, Álvaro Pinto Marín, Beatriz Castelo Fernández, Pilar Zamora Auñón, Manuel González Barón
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 30:356-361
Renal cell carcinoma therapy has changed in a very significant way in the last few years. Up to 5 new agents have been developed, improving the results previously achieved with cytokine therapy. Bevacizumab, sorafenib, sunitinib, temsirolimus, and ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32f966b6da83435c68ab010071861df9
https://doi.org/10.1016/j.urolonc.2009.11.008
https://doi.org/10.1016/j.urolonc.2009.11.008
Autor:
Enrique Espinosa Arranz, María Sereno Moyano, Beatriz Castelo Fernández, Manuel González Barón
Publikováno v:
Revista de Oncología. 5:500-510
Se ha visto que los canceres de cabeza y cuello tienen multiples anomalias geneticas que influyen en el desarrollo y comportamiento del tumor y pueden ser utiles para la creacion de nuevas terapias.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::548b741a74cd141f69e20f517d00c41f
https://doi.org/10.1007/bf02710397
https://doi.org/10.1007/bf02710397
Autor:
Beatriz Castelo Fernández, María Sereno Moyano, Manuel González Barón, Noelia Martínez Jáñez, Enrique Casado Sáenz
Publikováno v:
Revista de Oncología. 5:315-319
La cistitis hemorragica se define como un sangrado vesical difuso agudo o insidioso. Las causas potenciales de hemorragia vesical son numerosas; incluyen toxicos quimicos (agentes al quilantes como las oxazofosforinas, el busulfan, tiotepa, derivados
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e6de3383d86b920b202f9c9423e1f1d
https://doi.org/10.1007/bf02709986
https://doi.org/10.1007/bf02709986
Autor:
Beatriz, Rodríguez Vega, Carmen, Bayón Pérez, Guadalupe, Torres Sancho, Beatriz, Castelo Fernández
Publikováno v:
Medicina clinica. 130(17)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c038a8cd77b3cd20a49204c827925b50
https://pubmed.ncbi.nlm.nih.gov/18501133
https://pubmed.ncbi.nlm.nih.gov/18501133